Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

A Case of Mistaken Identity: TTP-like State Due to Heroin Overdose

Phani Borra, MD, Cory Edward Mellon, MD

Blood (2019) 134 (Supplement_1): 4905.

https://doi.org/10.1182/blood-2019-128537

Published: 2019

Journal Articles

Multicenter, Open-Label, 3-Arm Study of Gilteritinib, Gilteritinib Plus Azacitidine, or Azacitidine Alone in Newly Diagnosed FLT 3 Mutated ( FLT3 mut+ ) Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Induction Chemotherapy: Findings from the Safety Cohort

Jordi Esteve, MD PhD, Rik Schots, Teresa Bernal Del Castillo, MD PhD, Je-Hwan Lee, MD PhD, Eunice S. Wang, MD, Shira Dinner, MD, Mark D. Minden, MD PhD, Olga Salamero, MD, Jorge Sierra, MD, Goichi Yoshimoto, MD PhD, Kamel Laribi, MD, Janusz Halka, MD, Pau Montesinos, MD PhD, Shufang Liu, Elizabeth Shima Rich, MD PhD, Erkut Bahceci, MD

Blood (2018) 132 (Supplement 1): 2736.

https://doi.org/10.1182/blood-2018-99-110976

Published: 2018

Journal Articles

Evaluating and Correcting Iron Deficit in Atypical Hemolytic Uremic Syndrome (HUS)

Samuel B Reynolds, MD BS, William Tse, MD

Blood (2018) 132 (Supplement 1): 5002.

https://doi.org/10.1182/blood-2018-99-112353

Published: 2018

Journal Articles

Deficiency of Either Carboxypeptidase B2 or Carboxypeptidase N Exacerbated Disease Activity in a Mouse Model of Hemolytic Uremic Syndrome

Lawrence L. Leung, MD, Zhifei Shao, MD PhD, Toshihiko Nishimura, PhD, Qin Zhou, PhD, Laura Gigliello, Peter Castro, John Higgins, John Morser, PhD

Blood (2016) 128 (22): 3758.

https://doi.org/10.1182/blood.V128.22.3758.3758

Published: 2016

Journal Articles

Evaluation of Normal Reference Range of Schistocytes and Burr Cells in Healthy Adults

Mashrafi Ahmed, MD, Ashok R. Patel, MD

Blood (2015) 126 (23): 4540.

https://doi.org/10.1182/blood.V126.23.4540.4540

Published: 2015

Journal Articles

Autologous Hematopoietic Progenitor Cell Transplant in Patients with Multiple Myeloma in Hospital Central Sur De Alta Especialidad in Petróleos Mexicanos

Patricio Azaola, MD

Blood (2014) 124 (21): 5912.

https://doi.org/10.1182/blood.V124.21.5912.5912

Published: 2014

Journal Articles

MGUS Transformation Into Multiple Myeloma In Patients With Solid Organ Transplantation

Mohamad A. Younes, MD, Jonathan D Perez, MD, Zaid Alirhayim, MD, Cesar Ochoa, MD, Ruchir Patel, MD, Vrushali S. Dabak, MD

Blood (2013) 122 (21): 5325.

https://doi.org/10.1182/blood.V122.21.5325.5325

Published: 2013

Journal Articles

Patterns of CNS Involvement in Relapsed and/or Refractory Multiple Myeloma.

Al-Ola Abdallah, MD, Shebli Atrash, MD, Jameel Muzaffar, MD, Nisar Ahmad, MD, Sajjad Haider, MD, Monica Grazziutti, MD, Senu Apewokin, MD, Zainab Shahid, MD, Alejandro Restrepo, MD, Sarah Waheed, MD, Frits van Rhee, MD, PhD, Bart Barlogie, MD, PhD, Saad Z Usmani, MD FACP

Blood (2012) 120 (21): 2925.

https://doi.org/10.1182/blood.V120.21.2925.2925

Published: 2012

Journal Articles

Platelet Apoptosis in Uremic Patients

Ming Li, Tongling Ma, Guoyuan Lu, Kun Deng, Rong Yan, Kesheng Dai

Blood (2012) 120 (21): 4647.

https://doi.org/10.1182/blood.V120.21.4647.4647

Published: 2012

Journal Articles

The Risk of Thrombotic Events in Neonates Treated with Recombinant Factor VIIa.

John Puetz, MD, Ginger Darling, MD, Petr Brabec, M.Sc., Jan Blatny, MD PhD, Prasad Mathew, MD

Blood (2007) 110 (11): 3193.

https://doi.org/10.1182/blood.V110.11.3193.3193

Published: 2007

Journal Articles

Defective Responses of Uremic Platelets in ADP-Induced Platelet Aggregation.

Chi Chen, MD, PhD, Zili He, MD, Madhumati Kalavar, MD, Maged Khalil, MD, Alka Arora, MD, Seema Naik, MD, Theresa Dumlao, MD, Shyan-Yih Chou, MD, Williams Steier, MD

Blood (2006) 108 (11): 3992.

https://doi.org/10.1182/blood.V108.11.3992.3992

Published: 2006

Journal Articles

Influence of Renal Failure on the Osteoprotegerin Level in Patients with Multiple Myeloma.

Stefcho Goranov, PhD, DM, Veselina Goranova-Marinova, Emil Kumchev, PhD, Pavel Pavlov, Todorka Tzvetkova, PhD, DM

Blood (2006) 108 (11): 4999.

https://doi.org/10.1182/blood.V108.11.4999.4999

Published: 2006

Journal Articles

A Proteomic Approach to the Characterization of the Endothelial Dysfunction in Uremia.

Carla Carbo, Maribel Diaz-Ricart, PhD, Berta Fuste, PhD, Aleix Cases, MD, Montserrat Carrascal, PhD, Joaquin Abian, PhD, Antonio Ordinas, MD, Gines Escolar, MD

Blood (2005) 106 (11): 3955.

https://doi.org/10.1182/blood.V106.11.3955.3955

Published: 2005

Journal Articles

Laboratory Analysis of Abnormal Closure Times with Relation to Low Ristocetin Cofactor Versus Other Causes.

Emma Arthur, Andrea Cortese Hassett, Ph.D., Franklin A. Bontempo, M.D.

Blood (2004) 104 (11): 4010.

https://doi.org/10.1182/blood.V104.11.4010.4010

Published: 2004

Journal Articles

Use of Recombinant Human Erythropoietin Outside the Setting of Uremia

Mario Cazzola, Francesco Mercuriali, Carlo Brugnara

Blood (1997) 89 (12): 4248–4267.

https://doi.org/10.1182/blood.V89.12.4248

Published: 1997

Journal Articles

High von Willebrand factor concentration compensates a relative adhesion defect in uremic blood

JJ Zwaginga, MJ Ijsseldijk, N Beeser-Visser, PG de Groot, J Vos, JJ Sixma

Blood (1990) 75 (7): 1498–1508.

https://doi.org/10.1182/blood.V75.7.1498.1498

Published: 1990

Journal Articles

Abnormalities of cytoplasmic Ca2+ in platelets from patients with uremia

JA Ware, BA Clark, M Smith, EW Salzman

Blood (1989) 73 (1): 172–176.

https://doi.org/10.1182/blood.V73.1.172.172

Published: 1989

NARROW

A Case of Mistaken Identity: TTP-like State Due to Heroin Overdose

Multicenter, Open-Label, 3-Arm Study of Gilteritinib, Gilteritinib Plus Azacitidine, or Azacitidine Alone in Newly Diagnosed FLT 3 Mutated ( FLT3 mut+ ) Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Induction Chemotherapy: Findings from the Safety Cohort

Evaluating and Correcting Iron Deficit in Atypical Hemolytic Uremic Syndrome (HUS)

Deficiency of Either Carboxypeptidase B2 or Carboxypeptidase N Exacerbated Disease Activity in a Mouse Model of Hemolytic Uremic Syndrome

Evaluation of Normal Reference Range of Schistocytes and Burr Cells in Healthy Adults

Autologous Hematopoietic Progenitor Cell Transplant in Patients with Multiple Myeloma in Hospital Central Sur De Alta Especialidad in Petróleos Mexicanos

MGUS Transformation Into Multiple Myeloma In Patients With Solid Organ Transplantation

Patterns of CNS Involvement in Relapsed and/or Refractory Multiple Myeloma.

Platelet Apoptosis in Uremic Patients

The Risk of Thrombotic Events in Neonates Treated with Recombinant Factor VIIa.

Defective Responses of Uremic Platelets in ADP-Induced Platelet Aggregation.

Influence of Renal Failure on the Osteoprotegerin Level in Patients with Multiple Myeloma.

A Proteomic Approach to the Characterization of the Endothelial Dysfunction in Uremia.

Laboratory Analysis of Abnormal Closure Times with Relation to Low Ristocetin Cofactor Versus Other Causes.

Use of Recombinant Human Erythropoietin Outside the Setting of Uremia

High von Willebrand factor concentration compensates a relative adhesion defect in uremic blood

Abnormalities of cytoplasmic Ca2+ in platelets from patients with uremia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only